Alkermes Aims for Psychiatric Drug That Won’t Pack on the Pounds

From Xconomy
January 3, 2013 - 7:05am

Eli Lilly once made a fortune on a schizophrenia drug that helped a lot of people, but came with a nasty side effect—weight gain. Now Dublin, Ireland and Waltham, MA-based Alkermes is wagering that it can get the benefits of the original treatment without causing patients to add so many extra pounds. Alkermes (NASDAQ: ALKS) [...]


Share this article »  

Continue reading this article »